Acute Myeloid Leukemia Stocks List

Recent Signals

Date Stock Signal Type
2021-07-28 AIKI 20 DMA Resistance Bearish
2021-07-28 AIKI Bollinger Band Squeeze Range Contraction
2021-07-28 ALXO Crossed Above 50 DMA Bullish
2021-07-28 ALXO 20 DMA Support Bullish
2021-07-28 APRE Stochastic Buy Signal Bullish
2021-07-28 APRE Calm After Storm Range Contraction
2021-07-28 APRE Lower Bollinger Band Walk Weakness
2021-07-28 ARAV NR7 Range Contraction
2021-07-28 ARAV Stochastic Buy Signal Bullish
2021-07-28 ARGX Lower Bollinger Band Walk Weakness
2021-07-28 ARGX Morning Star Bullish
2021-07-28 ARGX 200 DMA Support Bullish
2021-07-28 ARGX 50 DMA Support Bullish
2021-07-28 ARGX 20 DMA Resistance Bearish
2021-07-28 ARGX Expansion Pivot Buy Setup Bullish Swing Setup
2021-07-28 ARGX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-07-28 BEAM NR7 Range Contraction
2021-07-28 CGEM Slingshot Bearish Bearish Swing Setup
2021-07-28 CLLS Slingshot Bearish Bearish Swing Setup
2021-07-28 CTIC 20 DMA Resistance Bearish
2021-07-28 CTIC Fell Below 50 DMA Bearish
2021-07-28 FBIO MACD Bullish Signal Line Cross Bullish
2021-07-28 FBIO Stochastic Buy Signal Bullish
2021-07-28 GLYC NR7 Range Contraction
2021-07-28 GLYC NR7-2 Range Contraction
2021-07-28 GLYC Narrow Range Bar Range Contraction
2021-07-28 HCWB Hot IPO Pullback Bullish Swing Setup
2021-07-28 KRON 20 DMA Resistance Bearish
2021-07-28 MBRX Bullish Engulfing Bullish
2021-07-28 MBRX Lower Bollinger Band Walk Weakness
2021-07-28 MRUS Slingshot Bearish Bearish Swing Setup
2021-07-28 NEXI NR7 Range Contraction
2021-07-28 NEXI New 52 Week Low Weakness
2021-07-28 SLS MACD Bullish Signal Line Cross Bullish
2021-07-28 SLS Pocket Pivot Bullish Swing Setup
2021-07-28 SLS 20 DMA Resistance Bearish
2021-07-28 SYRS Slingshot Bearish Bearish Swing Setup
2021-07-28 VOR Slingshot Bearish Bearish Swing Setup
2021-07-28 XBIO Upper Bollinger Band Walk Strength
2021-07-28 XBIO 1,2,3 Pullback Bullish Bullish Swing Setup
2021-07-28 XBIO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-07-28 XBIO Parabolic Rise Strength
2021-07-28 XBIO Pocket Pivot Bullish Swing Setup

Acute Myeloid Leukemia Stocks Recent News

Date Stock Title
Jul 29 GLYC GlycoMimetics to Report Second Quarter Financial Results on August 5, 2021
Jul 29 TRIL This Biotech Stock Is Too Cheap to Ignore
Jul 29 SYRS Syros to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
Jul 29 CTIC CTI BioPharma to Report Second Quarter 2021 Financial Results on August 5, 2021
Jul 29 ARGX Argenx SE reports 1H results
Jul 29 ARGX argenx Reports Half Year 2021 Financial Results and Provides Second Quarter Business Update
Jul 28 XBIO Xenetic Biosciences, Inc. Announces Closing of $12.5 Million Private Placement Priced at a Premium to Market
Jul 28 BEAM 11 Best Pharma and Biotech Stocks to Buy According to Jim Simons’ Euclidean Capital
Jul 28 SLS SELLAS Life Sciences to Host Virtual Investor Symposium on its Lead Asset, Galinpepimut-S, on August 17, 2021
Jul 28 ALXO Dosing underway in ALX Oncology/Merck's mid-stage ASPEN-04 study for head and neck cancer
Jul 28 VOR The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Jul 28 SYRS The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Jul 28 CGEM The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Jul 28 NEXI The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Jul 28 CLLS The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Jul 28 MBRX The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Jul 28 APTO The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Jul 28 ARAV The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Jul 28 ALXO ALX Oncology Announces First Patient Dosed in ASPEN-04, a Phase 2 Study of ALX148 in Combination with KEYTRUDA® (pembrolizumab) and Chemotherapy for the Treatment of Patients with Advanced Head and Neck Squamous Cell Carcinoma
Jul 28 BEAM Were Hedge Funds Right About Beam Therapeutics Inc. (BEAM)?

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cells. Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. Occasionally spread may occur to the brain, skin, or gums. As an acute leukemia, AML progresses rapidly and is typically fatal within weeks or months if left untreated.Risk factors include smoking, previous chemotherapy or radiation therapy, myelodysplastic syndrome, and exposure to the chemical benzene. The underlying mechanism involves replacement of normal bone marrow with leukemia cells, which results in a drop in red blood cells, platelets, and normal white blood cells. Diagnosis is generally based on bone marrow aspiration and specific blood tests. AML has several subtypes; for which treatments and outcomes may vary.AML, typically is initially treated with chemotherapy aimed at inducing remission. People may then go on to receive additional chemotherapy, radiation therapy, or a stem cell transplant. The specific genetic mutations present within the cancer cells may guide therapy, as well as determine how long that person is likely to survive. Arsenic trioxide may be tried in cases that have recurred following usual treatments.AML affected about one million people globally in 2015 and resulted in 147,000 deaths. It most commonly occurs in older adults. Males are affected more often than females. AML is curable in about 35% of people under 60 years old and 10% over 60 years old. Older people who are not healthy enough to receive intensive chemotherapy have a typical survival of 5–10 months. It accounts for roughly 1.8% of cancer deaths in the United States.

More about Acute Myeloid Leukemia
Browse All Tags